These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 27537382)
21. Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma. Springfeld C; Wiecha C; Kunzmann R; Heger U; Weichert W; Langer R; Stange A; Blank S; Sisic L; Schmidt T; Lordick F; Jäger D; Grenacher L; Bruckner T; Büchler MW; Ott K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S905-14. PubMed ID: 26001861 [TBL] [Abstract][Full Text] [Related]
22. A phase II trial of concurrent 3D-CRT/IMRT and oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) in gastric cancer patients with R0 gastrectomy and D2 lymph node dissection. Wang X; Shen Y; Zhu H; Zhao Y; Li Z; Qiu M; Li Q; Gou H; Yang Y; Cao D; Liu J; Yi C; Liao Z; Luo D; Bi F; Xu F Gastric Cancer; 2016 Jan; 19(1):245-54. PubMed ID: 25609451 [TBL] [Abstract][Full Text] [Related]
24. A randomized controlled pilot study to compare capecitabine-oxaliplatin with 5-FU-leucovorin as neoadjuvant concurrent chemoradiation in locally advanced adenocarcinoma of rectum. Saha A; Ghosh SK; Roy C; Saha ML; Choudhury KB; Chatterjee K J Cancer Res Ther; 2015; 11(1):88-93. PubMed ID: 25879343 [TBL] [Abstract][Full Text] [Related]
25. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction. Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330 [TBL] [Abstract][Full Text] [Related]
26. Survival Benefit of Induction Chemotherapy with Paclitaxel and Carboplatin Followed by Chemoradiation Versus Postoperative Treatment in Locally Advanced Gastric Cancer: A Retrospective Cohort Study. Azadeh P; Gholizadeh Pasha S; Yaghobi Joybari A; Abiar Z; Alahyari S; Taghizadeh-Hesary F J Gastrointest Cancer; 2024 Mar; 55(1):457-466. PubMed ID: 38010493 [TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer. Li ZY; Koh CE; Bu ZD; Wu AW; Zhang LH; Wu XJ; Wu Q; Zong XL; Ren H; Tang L; Zhang XP; Li JY; Hu Y; Shen L; Ji JF J Surg Oncol; 2012 Jun; 105(8):793-9. PubMed ID: 22189752 [TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study. Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262 [TBL] [Abstract][Full Text] [Related]
29. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358 [TBL] [Abstract][Full Text] [Related]
30. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163 [TBL] [Abstract][Full Text] [Related]
31. Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery. Arredondo J; Baixauli J; Pastor C; Chopitea A; Sola JJ; González I; A-Cienfuegos J; Martínez P; Rodriguez J; Hernández-Lizoain JL Clin Transl Oncol; 2017 Mar; 19(3):379-385. PubMed ID: 27496023 [TBL] [Abstract][Full Text] [Related]
32. Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy. Fareed KR; Ilyas M; Kaye PV; Soomro IN; Lobo DN; Parsons SL; Madhusudan S Histopathology; 2009 Oct; 55(4):399-406. PubMed ID: 19817890 [TBL] [Abstract][Full Text] [Related]
33. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study. Ozdemir N; Abali H; Vural M; Yalcin S; Oksuzoglu B; Civelek B; Oguz D; Bostanci B; Yalcin B; Zengin N Cancer Chemother Pharmacol; 2014 Dec; 74(6):1139-47. PubMed ID: 25234436 [TBL] [Abstract][Full Text] [Related]
34. Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases. Bhandare MS; Gundavda KK; Yelamanchi R; Chopde A; Batra S; Kolhe M; Ramaswamy A; Ostwal V; Deodhar K; Chaudhari V; Shrikhande SV Eur J Surg Oncol; 2024 Jun; 50(6):108343. PubMed ID: 38640606 [TBL] [Abstract][Full Text] [Related]
35. Complete Neoadjuvant Treatment for Rectal Cancer: The Brown University Oncology Group CONTRE Study. Perez K; Safran H; Sikov W; Vrees M; Klipfel A; Shah N; Schechter S; Oldenburg N; Pricolo V; Rosati K; Dipetrillo T Am J Clin Oncol; 2017 Jun; 40(3):283-287. PubMed ID: 25374145 [TBL] [Abstract][Full Text] [Related]
36. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom? De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847 [TBL] [Abstract][Full Text] [Related]
37. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma. Gerber N; Ilson DH; Wu AJ; Janjigian YY; Kelsen DP; Zheng J; Zhang Z; Bains MS; Rizk N; Rusch VW; Goodman KA Dis Esophagus; 2014 Apr; 27(3):235-41. PubMed ID: 23796070 [TBL] [Abstract][Full Text] [Related]
38. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. Voong KR; Rashid A; Crane CH; Minsky BD; Krishnan S; Yao JC; Wolff RA; Skibber JM; Feig BW; Chang GJ; Das P Am J Clin Oncol; 2017 Dec; 40(6):555-560. PubMed ID: 26237193 [TBL] [Abstract][Full Text] [Related]